Daunorubicin and Cytarabine (Liposomal) and Pneumococcal 13-valent conjugate vaccine
Determining the interaction of Daunorubicin and Cytarabine (Liposomal) and Pneumococcal 13-valent conjugate vaccine and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using DAUNOrubicin liposomal together with cytarabine liposomal or other chemotherapy drugs may increase the risk of side effects, especially those that affect the bone marrow or gastrointestinal tract. You may experience a greater number or more severe side effects such as nausea; vomiting; diarrhea; loss of appetite; mouth sores; abdominal pain; delayed wound healing; and impaired bone marrow function resulting in low numbers of different types of blood cells. You may also be more likely to develop anemia, bleeding problems, or infections due to low blood cell counts. You should seek medical attention if you develop paleness, fatigue, dizziness, fainting, unusual bruising or bleeding, fever, chills, diarrhea, sore throat, muscle aches, shortness of breath, blood in phlegm, weight loss, red or inflamed skin, body sores, and pain or burning during urination. You may need a dose adjustment or more frequent monitoring by your doctor to safely use these medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: The concomitant or sequential administration of multiple antineoplastic agents may result in additive toxicities, particularly in the bone marrow and gastrointestinal tract.
MANAGEMENT: Close clinical and laboratory monitoring for hematologic and nonhematologic toxicities are recommended when antineoplastic agents are administered concurrently or during close intervals. Dosing adjustments may be necessary. The manufacturers' recommendations and institutional protocols for dosage, treatment regimens, monitoring, and management of toxicities should be consulted.
- "Product Information. Ellence (epirubicin)" Pharmacia and Upjohn, Kalamazoo, MI.
- Agencia EspaƱola de Medicamentos y Productos Sanitarios Healthcare "Centro de informaciĆ³n online de medicamentos de la AEMPS - CIMA. Available from: URL: https://cima.aemps.es/cima/publico/home.html." ([2018]):
- "Product Information. Ifex (ifosfamide)." Bristol-Myers Squibb, Princeton, NJ.
- "Product Information. Fluorouracil injection (fluorouracil)." Roche Laboratories, Nutley, NJ.
- EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports. Available from: URL: http://www.ema.europa.eu/ema/index.jsp?curl=pages/includes/medicines/medicines_landingpage.jsp&mid."
- "Product Information. Zanosar (streptozocin)." Pharmacia and Upjohn, Kalamazoo, MI.
- "Product Information. Paraplatin (carboplatin)." Bristol-Myers Squibb, Princeton, NJ.
- Cerner Multum, Inc. "Australian Product Information." O 0
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
Generic Name: cytarabine liposomal / daunorubicin liposomal
Brand name: Vyxeos
Synonyms: Cytarabine and daunorubicin (liposomal)
Generic Name: pneumococcal 13-valent vaccine
Brand name: Prevnar 13
Synonyms: Pneumococcal Conjugate Vaccine (13-Valent)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daunorubicin and Cytarabine (Liposomal)-Pneumococcal 13-valent vaccine, diphtheria conjugate Intramuscular
- Daunorubicin and Cytarabine (Liposomal)-Pneumococcal Conjugate Vaccine (13-Valent)
- Daunorubicin and Cytarabine (Liposomal)-Pneumococcal Conjugate Vaccine (7-Valent)
- Daunorubicin and Cytarabine (Liposomal)-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Daunorubicin and Cytarabine (Liposomal)-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Daunorubicin and Cytarabine (Liposomal)-Pneumovax 23
- Pneumococcal 13-valent conjugate vaccine-Daunorubicin and cytarabine liposome Intravenous
- Pneumococcal 13-valent conjugate vaccine-Daunorubicin citrate
- Pneumococcal 13-valent conjugate vaccine-Daunorubicin citrate liposome Intravenous
- Pneumococcal 13-valent conjugate vaccine-Daunorubicin hydrochloride
- Pneumococcal 13-valent conjugate vaccine-Daunorubicin Intravenous
- Pneumococcal 13-valent conjugate vaccine-DaunoXome